Top

Published in:

01-12-2013 | Case Report

Pulmonary Hypertension in Kawasaki Disease

Authors: George T. Nicholson, Cyrus Samai, Usama Kanaan

Published in: Pediatric Cardiology | Issue 8/2013

Abstract

This report describes the case of two pediatric patients who demonstrated echocardiographic evidence of pulmonary hypertension (PH) during the acute phase of Kawasaki disease. The etiology of PH development in this setting is currently unknown, but the authors hypothesize that pulmonary vasculitis may play a significant role. Fortunately, the PH appeared to be self-limited and resolved in both cases with routine treatment of Kawasaki disease.

Archer SL, Weir K, Wilkins MR (2010) Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation 121:2045–2066PubMedCentralCrossRefPubMed

Hamamichi Y, Ichida F, Tsubata S et al (2002) Dobutamine stress radionuclide ventriculography reveals silent myocardial dysfunction in Kawasaki disease. Circ J 66:63–69CrossRefPubMed

Lin MT, Tsao LY, Cheng ML et al (2005) Absence of hypercoagulability in acute Kawasaki disease. Pediatr Int 47:126–131CrossRefPubMed

Mathew R (2010) Inflammation and pulmonary hypertension. Cardiol Rev 18:67–72CrossRefPubMed

Newburger JW, Fulton DR (2004) Kawasaki disease. Curr Opin Pediatr 16:508–514CrossRefPubMed

Senzaki H, Chen CH, Ishido H et al (2005) Arterial hemodynamics in patients after Kawasaki disease. Circulation 111:2119–2125CrossRefPubMed

Sugimoto M, Ishido H, Seki M, Masutani S, Tamai A, Senzaki H (2012) Findings in the pulmonary vascular bed in the remote phase after Kawasaki disease. Am J Cardiol 109:1219–1222CrossRefPubMed

Voelkel NF, Gomez-Arroyo JG, Abbate A, Bogaard HJ, Nicolls MR (2012) Pathobiology of pulmonary arterial hypertension and right ventricular failure. Eur Respir J. doi:10.1183/09031936.00046612

Title: Pulmonary Hypertension in Kawasaki Disease
Authors: George T. Nicholson
Cyrus Samai
Usama Kanaan
Publication date: 01-12-2013
Publisher: Springer US
Published in: Pediatric Cardiology / Issue 8/2013
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI: https://doi.org/10.1007/s00246-012-0510-6

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Pulmonary Hypertension in Kawasaki Disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2013

Right-Ventricular Global Longitudinal Strain May Predict Neo-Aortic Arch Obstruction After Norwood/Sano Procedure in Children With Hypoplastic Left Heart Syndrome

Atrial Septal Hematoma After Mitral Valve and Left Coronary Artery Surgery in a Child

Atrioventricular Valve Regurgitation in the Fetus With Atrioventricular Canal Defect: Transition From Prenatal to Postnatal Life

Fetal Left and Right Ventricle Myocardial Performance Index: Defining Normal Values for the Second and Third Trimesters—Single Tertiary Center Experience

Inflammatory Markers Are Elevated in Eisenmenger Syndrome

Severe Constrictive Pericarditis After Parvovirus B19 and Human Herpes Virus 6 Infection in a 9-Year-Old Girl

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page